newsIbezapolstat cured all 10 patients of their Clostridioides difficile infections…
20 November 2020 | By Hannah Balfour (European Pharmaceutical Review)
Ibezapolstat cured all 10 patients of their Clostridioides difficile infections and prevented recurrence for at least 30 days.